New cancer clinical trial: "CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer (mCRPC) Progressed During or After a Previous Docetaxel-based Chemotherapy

Published on: November 29, 2017 at 10:00AM
Conditions:   Prostate Cancer;   Castration-resistant Prostate Cancer
Intervention:   Drug: Cabazitaxel
Sponsor:   Consorzio Oncotech
Not yet recruiting
http://ift.tt/2AkPuLw